News

Genesis Pharmaceuticals Enterprises, a US-based pharmaceutical company with its principal operations in China, has launched three traditional Chinese medicines. The traditional Chinese medicines (TCMs) are Yi Mu Cao

The measures are expected to generate increased operational efficiencies and reduce costs while continuing to allow Sequenom to serve the needs of its current and future genetic analysis

The trial was sponsored by the National Cancer Institute (NCI) and led by the Eastern Cooperative Oncology Group under a clinical trials agreement between NCI and Bayer and

According to the company, the job cuts are expected to be completed by June 22, 2009. Arena believes that job reduction is necessary to reduce its cash usage

Dr Pardoll is an active member of the National Association of Healthcare Consultants and the founding past managing partner of the Center for Digestive Diseases in St Petersburg,

The Eurtac trial is the first prospective, randomized Phase III trial to investigate whether first line treatment with Tarceva is superior to chemotherapy in patients with epidermal growth

The proceeds of the offering will primarily be used to complete the company’s CE Mark application for the Neovasc Reducer product, a stent for the treatment of refractory

The Pfizer/ University College London (UCL) collaboration brings together the pioneering work of university researchers in the field of cell-based therapies and Pfizer’s expertise in the design and

According to Covidien, the Duet TRS reload offers preloaded tissue reinforcement on the Endo GIA universal range of laparoscopic staplers. The reinforcement material is a synthetic absorbable polymer